Modalis Therapeutics Corporation

09/24/2024 | Press release | Distributed by Public on 09/23/2024 21:03

Modalis Therapeutics to Present Epigenome Editing Technology (CRISPR-GNDM) and Data at the 5th Annual Genome Editing Therapeutics Summit